📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Posaconazole nanocrystals dry powder inhalers for the local treatment of invasive pulmonary aspergillosis. (2025)

First Author: Li X

Attributed to: Targeting the circadian clock to restore hepatitis B T-cell immunity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijpharm.2024.124938

PubMed Identifier: 39557177

Publication URI: http://europepmc.org/abstract/MED/39557177

Type: Journal Article/Review

Volume: 668

Parent Publication: International journal of pharmaceutics

ISSN: 0378-5173